Cambridge Investment Research Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.48M Buy
32,484
+9,277
+40% +$669K 0.01% 1441
2025
Q4
$1.48M Buy
23,207
+3,041
+15% +$187K ﹤0.01% 1788
2025
Q3
$1.27M Buy
20,166
+1,622
+9% +$113K ﹤0.01% 1863
2025
Q2
$1.38M Buy
18,544
+699
+4% +$54.9K ﹤0.01% 1705
2025
Q1
$1.57M Sell
17,845
-13,242
-43% -$1.25M 0.01% 1503
2024
Q4
$2.84M Sell
31,087
-9,928
-24% -$1.02M 0.01% 1125
2024
Q3
$4.59M Buy
41,015
+25,737
+168% +$2.57M 0.02% 844
2024
Q2
$1.5M Sell
15,278
-3,195
-17% -$317K 0.01% 1490
2024
Q1
$1.85M Sell
18,473
-40,509
-69% -$3.56M 0.01% 1319
2023
Q4
$5.3M Sell
58,982
-6,959
-11% -$555K 0.02% 674
2023
Q3
$5.06M Buy
65,941
+5,608
+9% +$465K 0.02% 639
2023
Q2
$5.05M Sell
60,333
-14,564
-19% -$1.18M 0.02% 655
2023
Q1
$6.32M Buy
74,897
+27,064
+57% +$2.32M 0.03% 524
2022
Q4
$3.9M Buy
47,833
+24,987
+109% +$2.01M 0.02% 716
2022
Q3
$1.62M Buy
22,846
+2,754
+14% +$247K 0.01% 1160
2022
Q2
$1.8M Buy
20,092
+1,682
+9% +$174K 0.01% 1097
2022
Q1
$2.06M Buy
18,410
+918
+5% +$108K 0.01% 1119
2021
Q4
$2.12M Sell
17,492
-12,535
-42% -$1.39M 0.01% 1114
2021
Q3
$3.02M Buy
30,027
+2,687
+10% +$296K 0.01% 867
2021
Q2
$3.19M Sell
27,340
-943
-3% -$113K 0.02% 862
2021
Q1
$3.11M Buy
28,283
+13,686
+94% +$1.49M 0.02% 783
2020
Q4
$1.46M Buy
14,597
+78
+0.5% +$7.23K 0.01% 1092
2020
Q3
$1.13M Sell
14,519
-3,195
-18% -$241K 0.01% 1114
2020
Q2
$1.23M Sell
17,714
-1,350
-7% -$85.1K 0.01% 1000
2020
Q1
$888K Sell
19,064
-401
-2% -$25.8K 0.01% 1031
2019
Q4
$1.54M Buy
19,465
+2,649
+16% +$204K 0.01% 917
2019
Q3
$1.24M Sell
16,816
-286
-2% -$20.5K 0.01% 963
2019
Q2
$1.33M Buy
17,102
+838
+5% +$63.7K 0.01% 896
2019
Q1
$1.23M Buy
16,264
+1,784
+12% +$142K 0.01% 931
2018
Q4
$1.06M Buy
14,480
+249
+2% +$19.9K 0.01% 902
2018
Q3
$1.36M Buy
14,231
+38
+0.3% +$3.77K 0.01% 855
2018
Q2
$1.42M Sell
14,193
-4,346
-23% -$459K 0.02% 792
2018
Q1
$1.96M Buy
18,539
+1,209
+7% +$122K 0.02% 634
2017
Q4
$1.6M Buy
17,330
+534
+3% +$48.5K 0.02% 668
2017
Q3
$1.52M Buy
16,796
+3,170
+23% +$270K 0.02% 639
2017
Q2
$1.14M Buy
13,626
+1,315
+11% +$106K 0.02% 742
2017
Q1
$995K Sell
12,311
-24,679
-67% -$1.94M 0.02% 728
2016
Q4
$2.78M Buy
36,990
+7,687
+26% +$555K 0.05% 334
2016
Q3
$1.98M Buy
29,303
+7,904
+37% +$530K 0.04% 436
2016
Q2
$1.45M Buy
21,399
+11,936
+126% +$877K 0.03% 460
2016
Q1
$684K Buy
9,463
+328
+4% +$21.5K 0.02% 733
2015
Q4
$617K Sell
9,135
-2,131
-19% -$149K 0.01% 763
2015
Q3
$729K Buy
11,266
+425
+4% +$31.4K 0.02% 587
2015
Q2
$887K Sell
10,841
-973
-8% -$75K 0.02% 550
2015
Q1
$818K Buy
11,814
+3,568
+43% +$258K 0.02% 581
2014
Q4
$626K Sell
8,246
-289
-3% -$22.8K 0.02% 662
2014
Q3
$690K Buy
8,535
+458
+6% +$38.2K 0.02% 657
2014
Q2
$706K Buy
8,077
+1,034
+15% +$89.8K 0.02% 584
2014
Q1
$607K Buy
7,043
+3,428
+95% +$281K 0.02% 619
2013
Q4
$292K Buy
3,615
+880
+32% +$68.3K 0.01% 897
2013
Q3
$213K Sell
2,735
-218
-7% -$16.8K 0.01% 1003
2013
Q2
$207K Buy
+2,953
New +$206K 0.01% 939

Other funds holding EMN